Availability: In Stock

Composition active ingredients panangin:

magnesium asparaginate, potassium asparaginate; 1 coated tablet contains 140 mg of magnesium asparaginate (as 175 mg of magnesium asparaginate tetrahydrate) equivalent to 11.8 mg of Mg 2+; 158 mg potassium asparaginate (as 166.3 mg potassium asparaginate hemihydrate) is equivalent to 36, 2 mg K +; excipients panangin: silicon dioxide colloidal potato starch; povidone, magnesium stearate talcum starch corn macrogol 6000; titanium dioxide, E 171; copolymer of methacrylate base (Eudragit E 100).

Indications for use

as an additional therapy in the treatment of chronic heart diseases (including heart failure, in the post-infarction period), cardiac arrhythmias (especially ventricular arrhythmias);
as adjunctive therapy in combination with cardiac glycosides;
as an additional source of potassium and magnesium ions.

Dosage regimen

The recommended dose is 1-2 tablets. 3 times / day If necessary, the dose can be increased to 3 tab. 3 times / day

Tablets should be taken after meals, as acidic environment of the stomach reduces the effectiveness of the preparation.

Side effects

From the digestive system:

perhaps - increased stool (when using the preparation in high doses).
acute and chronic renal failure;
Addison's disease;
AV block of the III degree;
cardiogenic shock (systolic blood pressure <90 mm Hg);
hypersensitivity to the components of the preparation.

Instructions For the use of medicine Panangin



Active ingredients: magnesium aspartate, potassium aspartate

1 coated  tablet contains: 140 mg magnesium aspartate , 158 mg potassium aspartate

Inactive ingredients: colloidal silica, potato starch, polyvinylpyrrolidone, magnesium stearate, con starch, macrogol 6000, titanium dioxide E 171

Medication form:  coated tablets

Physical and chemical properties: round flat beveled tablet, almost white coating, somewhat shiny, no distinct scent.

Pharmaceutical group: Mineral drug

Pharmaceutical properties:  Magnesium and potassium - is intracellular cations play an important role in the interaction of intracellular structures and macromolecules, in the functioning of many enzymes and the mechanism of muscle contraction. Low levels of these ions in the internal environment can cause metabolic changes in the myocardium have proaritmogennoe action (cause arrhythmia), lead to the development of hypertension. Aspartate, not only is a carrier of magnesium and potassium, but also contributes to their entry into the intracellular space.The combination of magnesium and potassium ions in the formulation Panangin is because the shortage of potassium in the body, usually also accompanied by a magnesium deficiency, and therefore the content of these ions correction requires simultaneous.


Clinical characteristics. post-myocardial infarction; cardiac arrhythmia (in the complex therapy);

chronic heart disease; treatment of cardiac glycosides (in the complex therapy);

replacement therapy with a deficiency of potassium / magnesium.

Contraindications:  Sensitivity to any of the ingredients.

the metabolism of amino acids; AV-blockade of I degree; myasthenia gravis; dehydration;

Acute metabolic acidosis; hemolysis; acute and chronic renal failure; gipermagniemiya; hyperkalemia;

cardiogenic shock (BP & lt; 90 mm Hg); Addison's disease; oliguria; anuria.

Interaction with other medical substances:  Panangin may interact with other drugs that you are currently taking, which can change how your drug works or increase your risk for serious side effects. To avoid any potential drug interactions, you should keep a list of all the drugs you are using (including prescription drugs, nonprescription drugs, and herbal products) and share it with your doctor and pharmacist. For your safety, do not start, stop, or change the dosage of any drugs without your doctor’s approval. Taking Panangin with tetracycline may decrease the absorption of Tetracycline.

Taking Panangin and Angiotensin-converting enzyme (ACE) inhibitors or Potassium-sparing diuretics may enhance the level of potassium in blood.

Application features:  Panangin may interact with your health condition. This interaction may worsen your health condition or alter the way the drug works. It is important to always let your doctor and pharmacist know all the health conditions you currently have, especially: Arrhythmias; Heart failure; Myocardial infarction.


Usage during pregnancy or breastfeeding: Toxicity of the ingredients has not been established. No known reactions have been reported.  Consult your health care provider if pregnant or breastfeeding.

Usage while operating machinery or driving: Unknown.  

Usage and Dosage:

Single dose:

For adults 1-2 tablets 3 times per day to completely dissolve in mouth. Dose can be increased to 3 tablets 3 times a day after a meal.

Treatment duration  as recommended by health care provider.

Children: the drug is not recommended for children over due to lack of research.

Overdose: no adverse reaction reported.

Side effects:  Although rarely possible hypersensitivity reaction may occur if the patient is hypersensitive to any of the ingredients.

Panangin tablets  can cause:of the cardiovascular system: blood pressure reduction, paradoxical reaction, AV-blockade; the central nervous and peripheral nervous system: paresthesia, cramps, hyporeflexia; Gastrointestinal: vomiting, nausea, diarrhea, discomfort in the area of ​​the pancreas;

Respiratory system: respiratory depression. In case of any unexpected reaction stop taking medication and consult with health care professional.

Shelf life: 5 years.  Do not use the product after expiration date indicated on the package.

Storage: Store medicines in original package at room temperature. Keep medicines away from children and pets.

Packaging: 50 tablets in polypropylene container in a box.

Manufacture’s address: Gedeon Richter, 1103 Budapest, Gyömrői út 19-21 Hungary





There are no reviews for this product.

Write a review

Buyers Online

Онлайн курсы IT